These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30091081)

  • 1. Long-Term Effects of Iloperidone on Cerebral Serotonin and Adrenoceptor Subtypes.
    Choi YK; Tarazi FI
    J Mol Neurosci; 2018 Sep; 66(1):59-67. PubMed ID: 30091081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effects of iloperidone on cerebral dopamine receptor subtypes.
    Kee Choi Y; Tarazi FI
    Synapse; 2018 Jun; ():e22039. PubMed ID: 29935022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of aripiprazole exposure on monoaminergic and glutamatergic receptor subtypes: comparison with cariprazine.
    Choi YK; Adham N; Kiss B; Gyertyán I; Tarazi FI
    CNS Spectr; 2017 Dec; 22(6):484-494. PubMed ID: 28059046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects of JL 13, a potential atypical antipsychotic, on rat dopamine and serotonin receptor subtypes.
    Moran-Gates T; Massari C; Graulich A; Liégeois JF; Tarazi FI
    J Neurosci Res; 2006 Aug; 84(3):675-82. PubMed ID: 16810690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism.
    Ichikawa J; Li Z; Dai J; Meltzer HY
    Brain Res; 2002 Nov; 956(2):349-57. PubMed ID: 12445705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effect of lurasidone and blonanserin on cortical glutamate, dopamine, and acetylcholine efflux: role of relative serotonin (5-HT)2A and DA D2 antagonism and 5-HT1A partial agonism.
    Huang M; Panos JJ; Kwon S; Oyamada Y; Rajagopal L; Meltzer HY
    J Neurochem; 2014 Mar; 128(6):938-49. PubMed ID: 24164459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of antipsychotic drugs on extracellular serotonin levels in rat medial prefrontal cortex and nucleus accumbens.
    Ichikawa J; Kuroki T; Dai J; Meltzer HY
    Eur J Pharmacol; 1998 Jun; 351(2):163-71. PubMed ID: 9686999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developmental effects of antipsychotic drugs on serotonin receptor subtypes.
    Choi YK; Gardner MP; Tarazi FI
    Synapse; 2017 Oct; 71(10):e21988. PubMed ID: 28597539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex vivo studies with iloperidone (HP 873), a potential atypical antipsychotic with dopamine D2/5-hydroxytryptamine2 receptor antagonist activity.
    Szczepanik AM; Brougham LR; Roehr JE; Conway PG; Ellis DB; Wilmot CA
    J Pharmacol Exp Ther; 1996 Aug; 278(2):913-20. PubMed ID: 8768747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of the novel antipsychotic aripiprazole with 5-HT1A and 5-HT 2A receptors: functional receptor-binding and in vivo electrophysiological studies.
    Stark AD; Jordan S; Allers KA; Bertekap RL; Chen R; Mistry Kannan T; Molski TF; Yocca FD; Sharp T; Kikuchi T; Burris KD
    Psychopharmacology (Berl); 2007 Feb; 190(3):373-82. PubMed ID: 17242925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of repeated risperidone exposure on serotonin receptor subtypes in developing rats.
    Choi YK; Moran-Gates T; Gardner MP; Tarazi FI
    Eur Neuropsychopharmacol; 2010 Mar; 20(3):187-94. PubMed ID: 19875272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended radioligand binding profile of iloperidone: a broad spectrum dopamine/serotonin/norepinephrine receptor antagonist for the management of psychotic disorders.
    Kalkman HO; Subramanian N; Hoyer D
    Neuropsychopharmacology; 2001 Dec; 25(6):904-14. PubMed ID: 11750183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation.
    Liégeois JF; Deville M; Dilly S; Lamy C; Mangin F; Résimont M; Tarazi FI
    J Med Chem; 2012 Feb; 55(4):1572-82. PubMed ID: 22268448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor profile of P88-8991 and P95-12113, metabolites of the novel antipsychotic iloperidone.
    Subramanian N; Kalkman HO
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Apr; 26(3):553-60. PubMed ID: 11999907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asenapine induces differential regional effects on serotonin receptor subtypes.
    Tarazi FI; Moran-Gates T; Wong EH; Henry B; Shahid M
    J Psychopharmacol; 2010 Mar; 24(3):341-8. PubMed ID: 18719049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of olanzapine and betahistine co-treatment on serotonin transporter, 5-HT2A and dopamine D2 receptor binding density.
    Lian J; Huang XF; Pai N; Deng C
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():62-8. PubMed ID: 23994047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regional and dose-related effects of asenapine on dopamine receptor subtypes.
    Tarazi FI; Moran-Gates T; Wong EH; Henry B; Shahid M
    Psychopharmacology (Berl); 2008 May; 198(1):103-11. PubMed ID: 18297468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacological profile of iloperidone, a novel atypical antipsychotic agent.
    Szewczak MR; Corbett R; Rush DK; Wilmot CA; Conway PG; Strupczewski JT; Cornfeldt M
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1404-13. PubMed ID: 7562515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risperidone dose-dependently increases extracellular concentrations of serotonin in the rat frontal cortex: role of alpha 2-adrenoceptor antagonism.
    Hertel P; Nomikos GG; Schilström B; Arborelius L; Svensson TH
    Neuropsychopharmacology; 1997 Jul; 17(1):44-55. PubMed ID: 9194049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of novel atypical antipsychotic, blonanserin, on extracellular neurotransmitter level in rat prefrontal cortex.
    Ohoyama K; Yamamura S; Hamaguchi T; Nakagawa M; Motomura E; Shiroyama T; Tanii H; Okada M
    Eur J Pharmacol; 2011 Feb; 653(1-3):47-57. PubMed ID: 21147094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.